Phanes Therapeutics
Clinical trials sponsored by Phanes Therapeutics, explained in plain language.
-
New drug trial targets tough digestive cancers
Disease control Recruiting nowThis early-stage study is testing a new drug called PT886 (spevatamig) in people with advanced stomach, pancreatic, or bile duct cancers that have spread or cannot be removed by surgery. The main goals are to find a safe dose, check for side effects, and see if the drug shows ear…
Phase: PHASE1, PHASE2 • Sponsor: Phanes Therapeutics • Aim: Disease control
Last updated Apr 04, 2026 03:35 UTC
-
New hope for Tough-to-Treat cancers: first human trial of experimental drug begins
Disease control Recruiting nowThis early-stage study is testing a new drug called PT217 for people with advanced neuroendocrine cancers that have spread or come back after standard treatments. Researchers will first find the safest dose of PT217 given alone, then test it combined with chemotherapy. The goal i…
Phase: PHASE1, PHASE2 • Sponsor: Phanes Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC